Evidence map›Paper›PMID 20213134›Full record

Trial reportPediatric nephrology (Berlin, Germany)2010

Bone metabolism in oxalosis: a single-center study using new imaging techniques and biomarkers.

Justine Bacchetta, Sonia Fargue, Stéphanie Boutroy, Odile Basmaison, Nicolas Vilayphiou, Ingrid Plotton, Fitsum Guebre-Egziabher, Bruno Dohin, Rémi Kohler, Pierre Cochat

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Pediatric nephrology (Berlin, Germany), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Meta-analyses of the quantitative computed tomography data in dialysis patients show differential impacts of renal failure on the trabecular and cortical bones.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Pooled it
  2. Article
  3. Diagnosis and management of primary hyperoxalurias: best practices.Pediatric nephrology (Berlin, Germany) · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. A stone in the bone.JIMD reports · 2021
    Article
  9. Article
  10. Review
  11. Children and adolescents with cystic fibrosis display moderate bone microarchitecture abnormalities: data from high-resolution peripheral quantitative computed tomography.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Article
  12. Bone impairment in primary hyperoxaluria: a review.Pediatric nephrology (Berlin, Germany) · 2016
    Review
  13. Update on oxalate crystal disease.Current rheumatology reports · 2013
    Review
  14. The consequences of chronic kidney disease on bone metabolism and growth in children.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2012
    Review
  15. Review
  16. CKD-MBD after kidney transplantation.Pediatric nephrology (Berlin, Germany) · 2011
    Review
  17. Article
  18. Primary hyperoxaluria.International journal of nephrology · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Justine BacchettaService de Néphrologie et Rhumatologie Pédiatriques, Centre de Référence des Maladies Rénales Rares, Hôpital Femme Mère Enfant, 59 Bd Pinel, 69677 Bron, France. justine.bacchetta@chu-lyon.fr
Sonia Fargue
Stéphanie Boutroy
Odile Basmaison
Nicolas Vilayphiou
Ingrid Plotton
Fitsum Guebre-Egziabher
Bruno Dohin
Rémi Kohler
Pierre Cochat

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The deposition of calcium oxalate crystals in the kidney and bone is a hallmark of primary hyperoxaluria type 1 (PH1). We report here an evaluation of the bone status of 12 PH1 children based on bone biomarkers [parathyroid hormone, vitamin D, fibroblast growth factor 23 (FGF23)] and radiological assessments (skeletal age, three-dimensional high-resolution peripheral quantitative computed tomography, HR-pQCT) carried out within the framework of a cross-sectional single-center study. The controls consisted of healthy and children with chronic kidney disease already enrolled in local bone and mineral metabolism studies. The mean age (+ or - standard deviation) age of the patients was 99 (+ or - 63) months. Six children suffered from fracture. Bone maturation was accelerated in five patients, four of whom were <5 years. The combination of new imaging techniques and biomarkers highlighted new and unexplained features of PH1: advanced skeletal age in young PH1 patients, increased FGF23 levels and decreased total volumetric bone mineral density with bone microarchitecture alteration.

Indexed as

AdolescentBiomarkersBone and BonesChildChild, PreschoolCross-Sectional StudiesFemaleFibroblast Growth Factor-23Fibroblast Growth FactorsHumansHyperoxaluria, PrimaryInfantMaleTomography, X-Ray ComputedYoung AdultBiomarkersFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.